Page 9 - Randomised Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

sudok1 / iStock Convalescent plasma given to hospitalized COVID-19 patients did not improve survival or rates of release from the hospital within 28 days, need for invasive mechanical ventilation, or death, according to the most recent findings of the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial in the United Kingdom. The results, published late last week in The Lancet, add to evidence that SARS-CoV-2 antibody-rich plasma taken from COVID-19 survivors doesn't benefit severely ill coronavirus patients. The RECOVERY trial is evaluating several possible treatments for hospitalized...

The study cautions against the use of plasma therapy due to insufficient evidence on its efficacy.

Tocilizumab, like other potential COVID-19 drug treatments, is in spot shortages around the world. In India, it's being allocated to states by the government. The UK National Health Service allows patients to receive only one dose. And in Canada, whose use of the drug was the spotlight of a CMAJ analysis yesterday, it's considered to be in tier 3 shortage, a status reserved for potential COVID-19 drugs that allows them to be withheld owing to scarcity. Canada's shortage could cause supply and demand issues, according to the researchers. They estimate that, if the drug is proven to reduce in-...

Published: 12:03 PM March 12, 2021    Dr Jakki Faccenda, respiratory consultant and one of the principal investigators for the study with research nurses. - Credit: NWAFT The North West Anglia NHS Foundation Trust has recruited its 600th patient to the study which is part of a national study into life-saving treatments for Covid-19. The Trust is one of the top 10 recruiting sites for the study, with one in five patients admitted to Hinchingbrooke and Peterborough City hospitals with Covid-19 participating in the trial. Dr Kanchan Rege, chief medical officer at the North West Anglia NHS Fo...

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world's largest clinical trial for COVID-19 treatments, has now expanded...